MLYS
Price
$9.56
Change
+$0.03 (+0.31%)
Updated
Feb 21 closing price
Capitalization
476.43M
85 days until earnings call
TELO
Price
$3.91
Change
-$0.27 (-6.46%)
Updated
Feb 21 closing price
Capitalization
116.37M
3 days until earnings call
Ad is loading...

MLYS vs TELO

Header iconMLYS vs TELO Comparison
Open Charts MLYS vs TELOBanner chart's image
Mineralys Therapeutics
Price$9.56
Change+$0.03 (+0.31%)
Volume$335.44K
Capitalization476.43M
Telomir Pharmaceuticals
Price$3.91
Change-$0.27 (-6.46%)
Volume$146.23K
Capitalization116.37M
MLYS vs TELO Comparison Chart
Loading...
MLYS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TELO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MLYS vs. TELO commentary
Feb 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MLYS is a Hold and TELO is a Hold.

Ad is loading...
COMPARISON
Comparison
Feb 23, 2025
Stock price -- (MLYS: $9.56 vs. TELO: $3.91)
Brand notoriety: MLYS and TELO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MLYS: 121% vs. TELO: 88%
Market capitalization -- MLYS: $476.43M vs. TELO: $116.37M
MLYS [@Biotechnology] is valued at $476.43M. TELO’s [@Biotechnology] market capitalization is $116.37M. The market cap for tickers in the [@Biotechnology] industry ranges from $393.7B to $0. The average market capitalization across the [@Biotechnology] industry is $2.51B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MLYS’s FA Score shows that 0 FA rating(s) are green whileTELO’s FA Score has 0 green FA rating(s).

  • MLYS’s FA Score: 0 green, 5 red.
  • TELO’s FA Score: 0 green, 5 red.
According to our system of comparison, MLYS is a better buy in the long-term than TELO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MLYS’s TA Score shows that 6 TA indicator(s) are bullish while TELO’s TA Score has 3 bullish TA indicator(s).

  • MLYS’s TA Score: 6 bullish, 3 bearish.
  • TELO’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, MLYS is a better buy in the short-term than TELO.

Price Growth

MLYS (@Biotechnology) experienced а -6.64% price change this week, while TELO (@Biotechnology) price change was -8.86% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.71%. For the same industry, the average monthly price growth was -2.01%, and the average quarterly price growth was +0.86%.

Reported Earning Dates

MLYS is expected to report earnings on May 19, 2025.

TELO is expected to report earnings on Feb 26, 2025.

Industries' Descriptions

@Biotechnology (-1.71% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MLYS($476M) has a higher market cap than TELO($116M). TELO YTD gains are higher at: -5.097 vs. MLYS (-22.340). TELO has higher annual earnings (EBITDA): -12.19M vs. MLYS (-168.35M). MLYS has more cash in the bank: 264M vs. TELO (1.27M). MLYS (0) and TELO (0) have equivalent revenues.
MLYSTELOMLYS / TELO
Capitalization476M116M410%
EBITDA-168.35M-12.19M1,381%
Gain YTD-22.340-5.097438%
P/E RatioN/AN/A-
Revenue00-
Total Cash264M1.27M20,853%
Total DebtN/AN/A-
TECHNICAL ANALYSIS
Technical Analysis
MLYSTELO
RSI
ODDS (%)
Bullish Trend 3 days ago
79%
N/A
Stochastic
ODDS (%)
Bullish Trend 3 days ago
79%
Bullish Trend 3 days ago
83%
Momentum
ODDS (%)
Bearish Trend 3 days ago
73%
Bearish Trend 3 days ago
90%
MACD
ODDS (%)
Bullish Trend 3 days ago
79%
Bearish Trend 3 days ago
89%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
83%
Bearish Trend 3 days ago
89%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
85%
Bearish Trend 3 days ago
90%
Advances
ODDS (%)
Bullish Trend 3 days ago
88%
Bullish Trend 10 days ago
80%
Declines
ODDS (%)
Bearish Trend 5 days ago
88%
Bearish Trend 3 days ago
89%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
88%
Bullish Trend 3 days ago
86%
Aroon
ODDS (%)
Bullish Trend 3 days ago
84%
Bearish Trend 3 days ago
90%
View a ticker or compare two or three
Ad is loading...
MLYS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TELO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HDRVX16.63-0.04
-0.24%
Janus Henderson Responsible Intl DivN
VCGAX34.64-0.62
-1.76%
VALIC Company I Systematic Core Fund
FSSKX80.14-1.61
-1.97%
Fidelity Stock Selec-Class K
EMCAX64.07-1.85
-2.81%
Empiric Class A
HCMIX29.55-1.08
-3.53%
HCM Tactical Growth I

MLYS and

Correlation & Price change

A.I.dvisor indicates that over the last year, MLYS has been loosely correlated with ABOS. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if MLYS jumps, then ABOS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MLYS
1D Price
Change %
MLYS100%
+0.31%
ABOS - MLYS
45%
Loosely correlated
+0.72%
IDYA - MLYS
40%
Loosely correlated
+0.55%
CELC - MLYS
40%
Loosely correlated
+0.15%
RCKT - MLYS
40%
Loosely correlated
-3.68%
ERAS - MLYS
39%
Loosely correlated
-3.42%
More

TELO and

Correlation & Price change

A.I.dvisor tells us that TELO and MLYS have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that TELO and MLYS's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TELO
1D Price
Change %
TELO100%
-6.46%
MLYS - TELO
32%
Poorly correlated
+0.31%
ENGN - TELO
29%
Poorly correlated
+2.78%
ALZN - TELO
27%
Poorly correlated
-6.12%
COGT - TELO
25%
Poorly correlated
-1.11%
AURA - TELO
22%
Poorly correlated
-1.57%
More